Voie d'immunisation et séquence d'administration de l ... - TEL

tel-00827710, version 1 - 29 May 2013
Nair, S., McLaughlin, C., Weizer, A., Su, Z., Boczkowski, D., Dannull, J., Vieweg, J., and
Gilboa, E. (2003). Injection of immature dendritic cells into adjuvant-treated skin obviates the
need for ex vivo maturation. J Immunol 171, 6275-6282.
Nguyen, K.B., Salazar-Mather, T.P., Dalod, M.Y., Van Deusen, J.B., Wei, X.Q., Liew, F.Y.,
Caligiuri, M.A., Durbin, J.E., and Biron, C.A. (2002). Coordinated and distinct roles for IFNalpha
beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol
169, 4279-4287.
Nicodemus, C.F., and Berek, J.S. (2010). TLR3 agonists as immunotherapeutic agents.
Immunotherapy 2, 137-140.
Nierkens, S., den Brok, M.H., Sutmuller, R.P., Grauer, O.M., Bennink, E., Morgan, M.E.,
Figdor, C.G., Ruers, T.J., and Adema, G.J. (2008). In vivo colocalization of antigen and CpG
[corrected] within dendritic cells is associated with the efficacy of cancer immunotherapy.
Cancer Res 68, 5390-5396.
Nolte, M.A., Leibundgut-Landmann, S., Joffre, O., and Reis e Sousa, C. (2007). Dendritic
cell quiescence during systemic inflammation driven by LPS stimulation of radioresistant
cells in vivo. J Exp Med 204, 1487-1501.
Obar, J.J., Khanna, K.M., and Lefrancois, L. (2008). Endogenous naive CD8+ T cell
precursor frequency regulates primary and memory responses to infection. Immunity 28, 859-
869.
Obar, J.J., and Lefrancois, L. (2010). Early signals during CD8 T cell priming regulate the
generation of central memory cells. J Immunol 185, 263-272.
Obst, R., van Santen, H.M., Mathis, D., and Benoist, C. (2005). Antigen persistence is
required throughout the expansion phase of a CD4(+) T cell response. J Exp Med 201, 1555-
1565.
Ohashi, K., Burkart, V., Flohe, S., and Kolb, H. (2000). Cutting edge: heat shock protein 60 is
a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164, 558-561.
Palucka, A.K., Dhodapkar, M.V., Paczesny, S., Ueno, H., Fay, J., and Banchereau, J. (2005).
Boosting vaccinations with peptide-pulsed CD34+ progenitor-derived dendritic cells can
expand long-lived melanoma peptide-specific CD8+ T cells in patients with metastatic
melanoma. J Immunother 28, 158-168.
Palucka, A.K., Ueno, H., Connolly, J., Kerneis-Norvell, F., Blanck, J.P., Johnston, D.A., Fay,
J., and Banchereau, J. (2006). Dendritic cells loaded with killed allogeneic melanoma cells
can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity. J
Immunother 29, 545-557.
Palucka, K., and Banchereau, J. (2012). Cancer immunotherapy via dendritic cells. Nat Rev
Cancer 12, 265-277.
Pannetier, C., Cochet, M., Darche, S., Casrouge, A., Zoller, M., and Kourilsky, P. (1993). The
sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a
function of the recombined germ-line segments. Proc Natl Acad Sci U S A 90, 4319-4323.
Paquette, R.L., Hsu, N.C., Kiertscher, S.M., Park, A.N., Tran, L., Roth, M.D., and Glaspy,
J.A. (1998). Interferon-alpha and granulocyte-macrophage colony-stimulating factor
differentiate peripheral blood monocytes into potent antigen-presenting cells. J Leukoc Biol
64, 358-367.
Pearce, E.L. (2010). Metabolism in T cell activation and differentiation. Curr Opin Immunol
22, 314-320.
248